Skip to main content
Top
Gepubliceerd in: Netherlands Heart Journal 11/2009

01-11-2009 | Case report

Phlebotomies as a treatment of serious heart failure due to haemochromatosis: a case report

Auteurs: R. V. H. P. Huijskes, K. Hoogenberg, A. C. P. Wiesfeld, M. E. J. Pijl, I. C. van Gelder

Gepubliceerd in: Netherlands Heart Journal | Uitgave 11/2009

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Haemochromatosis is a disturbance in the iron metabolism leading to excessive accumulation of iron in various organs such as the liver, pancreas, joints, skin, pituitary, testes and heart, with the last mentioned leading to heart failure. In this report we describe a patient with serious heart failure, attributed to homozygosity for C282Y in the haemochromatosis (HFE) gene, in whom repetitive phlebotomies led to normalisation of left ventricular function. (Neth Heart J 2009;17:438–41.)
Literatuur
1.
go back to reference Alustiza JM, Artetxe J, Castiella A, Agirre C, Emparanza JI, Otazua P, et al. MR quantification of hepatic iron concentration. Radiology. 2004;230:479–84. Alustiza JM, Artetxe J, Castiella A, Agirre C, Emparanza JI, Otazua P, et al. MR quantification of hepatic iron concentration. Radiology. 2004;230:479–84.
2.
go back to reference Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T. Penetrance of 845G—> A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet. 2002;359:211–8. Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T. Penetrance of 845G—> A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet. 2002;359:211–8.
3.
go back to reference Mahon NG, Coonar AS, Jeffery S, Coccolo F, Akiyu J, Zal B, et al. Haemochromatosis gene mutations in idiopathic dilated cardiomyopathy. Heart. 2000;84:541–7. Mahon NG, Coonar AS, Jeffery S, Coccolo F, Akiyu J, Zal B, et al. Haemochromatosis gene mutations in idiopathic dilated cardiomyopathy. Heart. 2000;84:541–7.
4.
go back to reference Grosberg SJ. Hemochromatosis and heart failure: presentation of a case with survival after three years' treatment by repeated venesection. Ann Intern Med. 1961;54:550–9. Grosberg SJ. Hemochromatosis and heart failure: presentation of a case with survival after three years' treatment by repeated venesection. Ann Intern Med. 1961;54:550–9.
5.
go back to reference Menahem S, Salmon AP, Dennett X. Haemochromatosis presenting as severe cardiac failure in a young adolescent. Int J Cardiol. 1990; 29:86–9. Menahem S, Salmon AP, Dennett X. Haemochromatosis presenting as severe cardiac failure in a young adolescent. Int J Cardiol. 1990; 29:86–9.
6.
go back to reference Oliveira e Silva A, Maciel L, Fernandes E, Pina R, Candeias O, de Freitas F. [Refractory heart failure in a 26-year-old woman with idiopathic hemochromatosis].Rev Port Cardiol. 1994;13:771–5. Oliveira e Silva A, Maciel L, Fernandes E, Pina R, Candeias O, de Freitas F. [Refractory heart failure in a 26-year-old woman with idiopathic hemochromatosis].Rev Port Cardiol. 1994;13:771–5.
7.
go back to reference Short EM, Winkle RA, Billingham ME. Myocardial involvement in idiopathic hemochromatosis. Morphologic and clinical improvement following venesection. Am J Med. 1981;70:1275–9. Short EM, Winkle RA, Billingham ME. Myocardial involvement in idiopathic hemochromatosis. Morphologic and clinical improvement following venesection. Am J Med. 1981;70:1275–9.
8.
go back to reference Adams PC, Reboussin DM, Barton JC, McLaren CE, Eckfeldt JH, McLaren GD, et al. Hemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med. 2005;352:1769–78. Adams PC, Reboussin DM, Barton JC, McLaren CE, Eckfeldt JH, McLaren GD, et al. Hemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med. 2005;352:1769–78.
9.
go back to reference Nielsen P, Carpinteiro S, Fischer R, Cabeda JM, Porto G, Gabbe EE. Prevalence of the C282Y and H63D mutations in the HFE gene in patients with hereditary haemochromatosis and in control subjects from Northern Germany. Br J Haematol. 1998;103:842–5. Nielsen P, Carpinteiro S, Fischer R, Cabeda JM, Porto G, Gabbe EE. Prevalence of the C282Y and H63D mutations in the HFE gene in patients with hereditary haemochromatosis and in control subjects from Northern Germany. Br J Haematol. 1998;103:842–5.
10.
go back to reference Steinberg KK, Cogswell ME, Chang JC, Caudill SP, McQuillan GM, Bowman BA, et al. Prevalence of C282Y and H63D mutations in the hemochromatosis (HFE) gene in the United States. JAMA. 2001;285:2216–22. Steinberg KK, Cogswell ME, Chang JC, Caudill SP, McQuillan GM, Bowman BA, et al. Prevalence of C282Y and H63D mutations in the hemochromatosis (HFE) gene in the United States. JAMA. 2001;285:2216–22.
11.
go back to reference Bassett ML, Halliday JW, Ferris RA, Powell LW. Diagnosis of hemochromatosis in young subjects: predictive accuracy of biochemical screening tests. Gastroenterology. 1984;87:628–33. Bassett ML, Halliday JW, Ferris RA, Powell LW. Diagnosis of hemochromatosis in young subjects: predictive accuracy of biochemical screening tests. Gastroenterology. 1984;87:628–33.
12.
go back to reference Chapman BA, Horton DM, Burt MJ, Romeril KR, Walmsley TA, Grant SJ, et al. Investigation of subjects with abnormal iron studies: role of the hepatic iron index. N Z Med J. 1994;107:504–7. Chapman BA, Horton DM, Burt MJ, Romeril KR, Walmsley TA, Grant SJ, et al. Investigation of subjects with abnormal iron studies: role of the hepatic iron index. N Z Med J. 1994;107:504–7.
13.
go back to reference Milman N, Pedersen P, Steig T, Byg KE, Graudal N, Fenger K. Clinically overt hereditary hemochromatosis in Denmark 1948–1985: epidemiology, factors of significance for long-term survival, and causes of death in 179 patients. Ann Hematol. 2001;80:737–44. Milman N, Pedersen P, Steig T, Byg KE, Graudal N, Fenger K. Clinically overt hereditary hemochromatosis in Denmark 1948–1985: epidemiology, factors of significance for long-term survival, and causes of death in 179 patients. Ann Hematol. 2001;80:737–44.
14.
go back to reference Niederau C, Fischer R, Purschel A, Stremmel W, Haussinger D, Strohmeyer G. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology. 1996;110:1107–19. Niederau C, Fischer R, Purschel A, Stremmel W, Haussinger D, Strohmeyer G. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology. 1996;110:1107–19.
15.
go back to reference Caines AE, Kpodonu J, Massad MG, Chaer R, Evans A, Lee JC, et al. Cardiac transplantation in patients with iron overload cardiomyopathy. J Heart Lung Transplant. 2005;24:486–8. Caines AE, Kpodonu J, Massad MG, Chaer R, Evans A, Lee JC, et al. Cardiac transplantation in patients with iron overload cardiomyopathy. J Heart Lung Transplant. 2005;24:486–8.
Metagegevens
Titel
Phlebotomies as a treatment of serious heart failure due to haemochromatosis: a case report
Auteurs
R. V. H. P. Huijskes
K. Hoogenberg
A. C. P. Wiesfeld
M. E. J. Pijl
I. C. van Gelder
Publicatiedatum
01-11-2009
Uitgeverij
Bohn Stafleu van Loghum
Gepubliceerd in
Netherlands Heart Journal / Uitgave 11/2009
Print ISSN: 1568-5888
Elektronisch ISSN: 1876-6250
DOI
https://doi.org/10.1007/BF03086299

Andere artikelen Uitgave 11/2009

Netherlands Heart Journal 11/2009 Naar de uitgave